Nature Reviews Cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Nature Reviews Cancer
Jun 30, 2024, 05:23 |
Blog
María Mayán: How and why becoming an editor
María Mayán, Research Group Leader at CINBIO, shared on X/Twitter: . "Lunch session with editors:…
Jun 22, 2024, 13:55 |
Insight
"Why do patients with cancer die?" by Adrienne Boire et al.
Recently, Thomas R. Cox, Lab Head of Matrix and Metastasis Lab, shared a post on…
Jun 21, 2024, 18:05 |
Blog
Nature Reviews Cancer - Exploiting temporal aspects of cancer immunotherapy
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital,…
May 29, 2024, 08:36 |
Insight
A new review summarizing the different antibody-based approaches for targeting cancer cells - Nature Reviews Cancer
Nature Reviews Cancer shared a post on X: "Don´t miss this review summarizing the different…
Feb 23, 2024, 17:36 |
Blog
Runcie Chidebe: Diversity, equity, and inclusion have become the catchwords for getting funded for oncology research and many health projects
Runcie Chidebe, Executive Director at Project PINK BLUE, recently posted on LinkedIn: "I am so…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube